Rationale and protocol of MetNET-2 trial: Lanreotide Autogel plus metformin in advanced gastrointestinal or lung neuroendocrine tumors (Q38674812)
Jump to navigation
Jump to search
scientific article published on 05 June 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | Rationale and protocol of MetNET-2 trial: Lanreotide Autogel plus metformin in advanced gastrointestinal or lung neuroendocrine tumors |
scientific article published on 05 June 2017 |
Statements
1 reference
Rationale and protocol of MetNET-2 trial: Lanreotide Autogel plus metformin in advanced gastrointestinal or lung neuroendocrine tumors (English)
1 reference
Giuseppe Lo Russo
Daniela Femia
Massimo Milione
Elena Tamborini
Laura Concas
Iolanda Pulice
Francesca Corti
Roberto Buzzoni
5 June 2017
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference